bromocriptine has been researched along with Cancer, Second Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liberante, FG; McMullin, MF; Mills, KI; Pouryahya, T; Zhang, SD | 1 |
| Alfonso Collado, JI; Domínguez Ugidos, LJ; Martínez Subías, J; Sancho Serrano, E; Urpegui García, A; Vallés Varela, H | 1 |
1 review(s) available for bromocriptine and Cancer, Second Primary
| Article | Year |
|---|---|
[Invasive giant prolactinoma].
Topics: Adult; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasms, Second Primary; Pituitary Neoplasms; Prolactinoma; Skull Base Neoplasms | 1998 |
1 other study(ies) available for bromocriptine and Cancer, Second Primary
| Article | Year |
|---|---|
Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Bromocriptine; Case-Control Studies; Cell Proliferation; Dopamine Agonists; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Tumor Cells, Cultured | 2016 |